Gaelen Guzman

Gaelen Guzman

Auto-generated profile, based on publicly available information

Gaelen Guzman

Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2017 in eLife
Verified
Journal Article
Open access
VHVictoria Hung
Victoria Hung
SLStephanie S Lam
Stephanie S Lam
NUNamrata D Udeshi
Namrata D Udeshi
TSTanya Svinkina
Tanya Svinkina
GGGaelen Guzman
Gaelen Guzman
ATAlice Y Ting
Alice Y Ting
The cytosol-facing membranes of cellular organelles contain proteins that enable signal transduction, regulation of morphology and trafficking, protein import and export, and other specialized processes. Discovery of these proteins by traditional biochemical fractionation can be plagued with contaminants and loss of key components. Using peroxidase-mediated proximity biotinylation, we captured and identified endogenous proteins on the outer mitochondrial membrane (OMM) and endoplasmic reticulum membrane (ERM) of living human fibroblasts. The proteomes of 137 and 634 proteins, respectively, are highly specific and highlight 94 potentially novel mitochondrial or ER proteins. Dataset intersection identified protein candidates potentially localized to mitochondria-ER contact sites. We found that one candidate, the tail-anchored, PDZ-domain-containing OMM protein SYNJ2BP, dramatically increases mitochondrial contacts with rough ER when overexpressed. Immunoprecipitation-mass spectrometry identified ribosome-binding protein 1 (RRBP1) as SYNJ2BP’s ERM binding partner. Our results highlight the power of proximity biotinylation to yield insights into the molecular composition and function of intracellular membranes.

18 February 2022 in Science Immunology
Verified
Journal Article
Open access
TBTimothy A Bates
Timothy A Bates
SMSavannah K. McBride
Savannah K. McBride
HLHans C. Leier
Hans C. Leier
GGGaelen Guzman
Gaelen Guzman
ZLZoe Lyski
Zoe Lyski
FTFikadu Tafesse
Fikadu Tafesse
Current coronavirus disease 2019 (COVID-19) vaccines effectively reduce overall morbidity and mortality and are vitally important to controlling the pandemic. Individuals who previously recovered from COVID-19 have enhanced immune responses after vaccination (hybrid immunity) compared with their naïve-vaccinated peers; however, the effects of post-vaccination breakthrough infections on humoral immune response remain to be determined. Here, we measure neutralizing antibody responses from 104 vaccinated individuals, including those with breakthrough infections, hybrid immunity, and no infection history. We find that human immune sera after breakthrough infection and vaccination after natural infection broadly neutralize SARS-CoV-2 (severe acute respiratory coronavirus 2) variants to a similar degree. Although age negatively correlates with antibody response after vaccination alone, no correlation with age was found in breakthrough or hybrid immune groups. Together, our data suggest that the additional antigen exposure from natural infection substantially boosts the quantity, quality, and breadth of humoral immune response regardless of whether it occurs before or after vaccination.

1 June 2017 in Cell
Verified
Journal Article
Closed access
VRVictor Rusu
Victor Rusu
EHEitan Hoch
Eitan Hoch
JMJosep M. Mercader
Josep M. Mercader
DTDanielle E. Tenen
Danielle E. Tenen
MGMelissa Gymrek
Melissa Gymrek
MCMaria L. Cortes
Maria L. Cortes

9 March 2018 in Science
Verified
Journal Article
Closed access
PDF file
VMVishnu Mohanan
Vishnu Mohanan
TNToru Nakata
Toru Nakata
ADA. Nicole Desch
A. Nicole Desch
CLChloé Lévesque
Chloé Lévesque
ABAngela Boroughs
Angela Boroughs
RXRamnik J. Xavier
Ramnik J. Xavier
Overcoming a barrier to IBD: Inflammatory bowel disease (IBD) is a group of disorders linked to inflammation of the gastrointestinal tract. Colitis is a type of IBD that affects the inner lining of the colon and has been linked to a gene known as C1orf106 . Mohanan et al. found that C1orf106 encodes a protein that stabilizes the integrity of epithelial junctions and enhances barrier defense (see the Perspective by Citi). IBD-associated mutations in C1orf106 lead to greater cytohesin-1 protein levels, changes in E-cadherin localization, and enhanced susceptibility to intestinal pathogens. Modulation of C1orf106 may thus hold promise for treating colitis and other IBDs. Science , this issue p. 1161 ; see also p. 1097

1 December 2016 in Cell Reports
Verified
Journal Article
Open access
DGDaniel B. Graham
Daniel B. Graham
ALAriel Lefkovith
Ariel Lefkovith
PDPatrick Deelen
Patrick Deelen
NKNiek de Klein
Niek de Klein
MVMukund Varma
Mukund Varma
RXRamnik J. Xavier
Ramnik J. Xavier
Significant insights into disease pathogenesis have been gleaned from population-level genetic studies; however, many loci associated with complex genetic disease contain numerous genes, and phenotypic associations cannot be assigned unequivocally. In particular, a gene-dense locus on chromosome 11 (61.5-61.65 Mb) has been associated with inflammatory bowel disease, rheumatoid arthritis, and coronary artery disease. Here, we identify TMEM258 within this locus as a central regulator of intestinal inflammation. Strikingly, Tmem258 haploinsufficient mice exhibit severe intestinal inflammation in a model of colitis. At the mechanistic level, we demonstrate that TMEM258 is a required component of the oligosaccharyltransferase complex and is essential for N-linked protein glycosylation. Consequently, homozygous deficiency of Tmem258 in colonic organoids results in unresolved endoplasmic reticulum (ER) stress culminating in apoptosis. Collectively, our results demonstrate that TMEM258 is a central mediator of ER quality control and intestinal homeostasis.

23 February 2021 in mBio
Verified
Journal Article
Open access
PDF file
PNPatrick Niekamp
Patrick Niekamp
GGGaelen Guzman
Gaelen Guzman
HLHans C. Leier
Hans C. Leier
ARAli Rashidfarrokhi
Ali Rashidfarrokhi
VRVeronica Richina
Veronica Richina
FTFikadu Tafesse
Fikadu Tafesse
Mycobacterium tuberculosis ( Mtb ) invades alveolar macrophages through phagocytosis to establish infection and cause disease. The molecular mechanisms underlying Mtb entry are still poorly understood.